AbstractThe disease burden from non–small cell lung cancer (NSCLC) adenocarcinoma is substantial, with a million new cases diagnosed globally each year and a 5-year survival rate of less than 20%. The ...
Abstract. Small molecules that modulate protein complexes have transformed cell biology and oncology, yet few chemical starting points exist to probe protein-protein interactions. To expand this space ...
Abstract:. China has approved the first CAR T-cell therapy that targets solid tumors, satricabtagene autoleucel (satri-cel), for patients with claudin 18.2–positive, HER2-negative gastric or ...
1Department of Pathology, School of Basic Medical Sciences, Xuzhou Medical University, Xuzhou, China. 2Department of Human Anatomy, School of Basic Medical Sciences, Xuzhou Medical University, Xuzhou, ...
Clin Cancer Res (2026) 32 (14_Supplement): A015. In contrast to non-small cell lung cancer and pancreatic cancer, KRAS inhibitors exhibited limited single agent activities in colorectal cancer (CRC), ...
Cancer Discov (2026) 16 (8): OF1.
Cancer Discov (2026) 16 (8): OF1.
Cancer Discov (2026) 16 (8): OF1.
Cancer Discov (2026) 16 (8): OF1.
Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
, School of Medicine, Hangzhou, China. 2Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumors of Zhejiang Province, Hangzhou, China.
Cancer Discov (2026) 16 (8): OF1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results